Table 1.
Demographic characteristics
ITT population | mITT population | |||
---|---|---|---|---|
Besifloxacin [n = 16] | Gatifloxacin [n = 17] | Besifloxacin [n = 13] | Gatifloxacin [n = 9] | |
Age, days | ||||
Mean (SD) | 15.8 (6.39) | 15.2 (5.75) | 15.9 (6.01) | 15.4 (4.48) |
Min, max | 6, 26 | 5, 25 | 6, 25 | 11, 25 |
Gender | ||||
Male | 4 (25.0) | 10 (58.8) | 3 (23.1) | 7 (77.8) |
Female | 12 (75.0) | 7 (41.2) | 10 (76.9) | 2 (22.2) |
Race | ||||
Asian | 1 (6.3) | 1 (5.9) | 1 (7.7) | 1 (11.1) |
Black/African American | 0 | 1 (5.9) | 0 | 1 (11.1) |
White | 12 (75.0) | 12 (70.6) | 10 (76.9) | 6 (66.7) |
Other | 3 (18.8) | 3 (17.6) | 2 (15.4) | 1 (11.1) |
Data are expressed as n (%) unless otherwise specified
ITT intent-to-treat, mITT modified intent-to-treat, SD standard deviation, Min minimum, Max maximum